IMS Capital Management - INVIVO THERAPEUTICS HLDGS CO ownership

Back to all holdings Add to watchlist

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 22 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
IMS Capital Management ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$7,000
-22.2%
20,1460.0%0.00%
-20.0%
Q4 2021$9,000
-35.7%
20,1460.0%0.01%
-37.5%
Q3 2021$14,000
+75.0%
20,146
+98.5%
0.01%
+60.0%
Q2 2021$8,000
-20.0%
10,149
-0.0%
0.01%
-16.7%
Q1 2021$10,000–10,152–0.01%–
 Download
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q3 2021
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 81,491$116,0000.01%
NewSquare Capital LLC 62$00.00%
UBS Group AG 6,303$9,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 32$00.00%
Jacobi Capital Management LLC 1$00.00%
BANK OF AMERICA CORP /DE/ 39$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 1$00.00%
WELLS FARGO & COMPANY/MN 32$00.00%
NORTHERN TRUST CORP 12,751$18,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders